![]() |
Volumn 49, Issue 6, 1996, Pages 687-690
|
Can protocol-specified doses of chemotherapy and radiotherapy be used as a measure of treatment actually received? A CCG/NIH study on long-term survivors of acute lymphocytic leukemia
a,b
b,e
e
NONE
(United States)
|
Author keywords
Acute lymphocytic leukemia; Chemotherapy; Clinical trials; Compliance; Radiation; Survivors
|
Indexed keywords
CYCLOPHOSPHAMIDE;
DAUNORUBICIN;
DOXORUBICIN;
METHOTREXATE;
ACUTE LYMPHOCYTIC LEUKEMIA;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER SURVIVAL;
CLINICAL PROTOCOL;
GENDER;
HUMAN;
INTRATHECAL DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
RADIATION DOSE;
RELAPSE;
TREATMENT OUTCOME;
|
EID: 0029945151
PISSN: 08954356
EISSN: None
Source Type: Journal
DOI: 10.1016/0895-4356(96)00029-7 Document Type: Article |
Times cited : (8)
|
References (9)
|